The Patent Finder

Maintenance fees coming due

Bayer Pharma Aktiengesellschaft

42 maintenance fees come due in the 12 months from Nov 14, 2026, the next on Nov 19, 2026. Unpaid by May 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 9,035,023Bombesin Analog Peptide Antagonist Conjugates
In force
Fee due Nov 19, 2026
Lapses if unpaid May 19, 2027
 · High confidence
Bayer Pharma AktiengesellschaftIn forceNov 19, 2026May 19, 2027High confidence
US 11,660,301Combination of Atr Kinase Inhibitors with Parp Inhibitors
In force
Fee due Nov 30, 2026
Lapses if unpaid Jun 1, 2027
 · High confidence
Bayer Pharma AktiengesellschaftIn forceNov 30, 2026Jun 1, 2027High confidence
US 11,660,351Antibody Drug Conjugates (ADCS) Having Enzymatically Cleavable Groups
In force
Fee due Nov 30, 2026
Lapses if unpaid Jun 1, 2027
 · High confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceNov 30, 2026Jun 1, 2027High confidence
US 10,308,634New Substituted Indazoles, Methods for the Production Thereof, Pharmaceutical Preparations That Contain Said New Substituted Indazoles, and Use of Said New Substituted Indazoles to Produce Drugs
In force
Fee due Dec 4, 2026
Lapses if unpaid Jun 4, 2027
 · High confidence
Bayer Pharma AktiengesellschaftIn forceDec 4, 2026Jun 4, 2027High confidence
US 11,667,675Masp Inhibitory Compounds and Uses Thereof
In force
Fee due Dec 6, 2026
Lapses if unpaid Jun 7, 2027
 · High confidence
Bayer AktiengesellschaftIn forceDec 6, 2026Jun 7, 2027High confidence
US 9,051,316Substituted 4-ARYL-1,4-Dihydro-1,6-Naphthyridine Amides and Their Use
In force
Fee due Dec 9, 2026
Lapses if unpaid Jun 9, 2027
 · High confidence
Bayer Pharma AktiengesellschaftIn forceDec 9, 2026Jun 9, 2027High confidence
US 10,316,001Method for Producing (4S)-4-[4-Cyano-2-(METHYLSULFONYL)PHENYL]-3,6-Dimethyl-2-OXO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,3,4-Tetrahydro PYRIMIDINE-5-Carbonitrile
In force
Fee due Dec 11, 2026
Lapses if unpaid Jun 11, 2027
 · High confidence
PH Pharma Co. Ltd.In forceDec 11, 2026Jun 11, 2027High confidence
US 10,323,020Substituted Piperidinyl Tetrahydroquinolines
In force
Fee due Dec 18, 2026
Lapses if unpaid Jun 21, 2027
 · Medium confidence
Bayer Pharma AktiengesellschaftIn forceDec 18, 2026Jun 21, 2027Medium confidence
US 11,684,621Combination Containing SGC Stimulators and Mineralocorticoid Receptor Antagonists
In force
Fee due Dec 27, 2026
Lapses if unpaid Jun 28, 2027
 · Medium confidence
Bayer Pharma AktiengesellschaftIn forceDec 27, 2026Jun 28, 2027Medium confidence
US 11,684,672Combinations of Copanlisib with ANTI-PD-1 Antibody
In force
Fee due Dec 27, 2026
Lapses if unpaid Jun 28, 2027
 · High confidence
Bayer Pharma AktiengesellschaftIn forceDec 27, 2026Jun 28, 2027High confidence
32 more maintenance fees coming due in the 12 months from Nov 14, 2026 · Pro
10 of 42 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited